Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) Announces Earnings Results

Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) issued its quarterly earnings data on Wednesday. The company reported $0.91 earnings per share (EPS) for the quarter, Zacks reports. Recordati Industria Chimica E Farmaceutica had a net margin of 18.38% and a return on equity of 34.46%. The company had revenue of $810.70 million during the quarter.

Recordati Industria Chimica E Farmaceutica Price Performance

Shares of RCDTF stock opened at $58.00 on Friday. Recordati Industria Chimica E Farmaceutica has a twelve month low of $55.88 and a twelve month high of $60.00. The company has a market capitalization of $11.97 billion, a PE ratio of 20.69 and a beta of 0.25. The company has a current ratio of 1.26, a quick ratio of 0.86 and a debt-to-equity ratio of 0.85. The firm has a fifty day simple moving average of $58.71 and a 200-day simple moving average of $59.35.

About Recordati Industria Chimica E Farmaceutica

Recordati Industria Chimica e Farmaceutica is an Italy‐based international pharmaceutical company engaged in the research, development, manufacturing and commercialization of therapeutic products. Established in 1926, the company has built a diversified portfolio that includes proprietary drugs, generics and orphan medicines, with a particular emphasis on treatments for rare diseases. Recordati’s product range spans cardiovascular, urology, endocrinology, dermatology and oncology therapies, as well as specialized formulations for genetic and metabolic disorders.

The company’s historical roots date back nearly a century, when it began as a family‐owned enterprise in Milan.